Isolation of heparin-insensitive aortic smooth muscle cells. Growth and differentiation.
- 1 May 1993
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 13 (5) , 748-757
- https://doi.org/10.1161/01.atv.13.5.748
Abstract
Previous work has shown heparin and heparan sulfates to be potent inhibitors of vascular smooth muscle cell (VSMC) growth. This laboratory has previously isolated a VSMC line insensitive to the antiproliferative action of heparin by subjecting VSMCs that grew out from rat aortic medial explants to continuous passage in media containing heparin at 200 micrograms/mL. In the present study, we have isolated two additional heparin-resistant (HR) cell lines and have used the HR cells to investigate cellular mechanisms responsible for the potent antiproliferative activity of heparin. In contrast to normal heparin-sensitive VSMCs, the HR cells were smaller, displayed elongated processes, and possessed altered growth characteristics; however, both HR and normal cells bound and internalized comparable amounts of heparin. Immunohistochemical detection of smooth muscle cell-specific actin in growth-arrested cells showed staining of nearly all normal VSMCs and of a much smaller percentage of HR cells; heparin treatment caused a marked increase in the percentage of HR cells expressing smooth muscle cell alpha-actin, indicating that the antiproliferative and differentiation-promoting actions of heparin are independent. Proteins from control VSMCs and HR cells were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and heparin affinity chromatography. Several proteins were expressed preferentially by either HR cells or normal VSMCs, with the most significant difference being the secretion of a high-affinity, heparin-binding protein (M(r), 38,000) by control VSMCs but not by HR cells. We conclude that the aortic VSMC population may give rise to HR cells under selective conditions and that their unique characteristics, such as alterations in their ability to produce heparin-binding proteins, will prove useful in deciphering the cellular mechanisms involved in heparin's regulation of VSMC growth and differentiation.Keywords
This publication has 21 references indexed in Scilit:
- Regulation of differentiated properties and proliferation of arterial smooth muscle cells.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells [published erratum appears in J Cell Biol 1990 Mar;110(3):863]The Journal of cell biology, 1989
- Structure of Heparin and Heparin FragmentsAnnals of the New York Academy of Sciences, 1989
- Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state.The Journal of cell biology, 1988
- In vitro expression of a 38,000 dalton heparin‐binding glycoprotein by morphologically differentiated smooth muscle cellsJournal of Cellular Physiology, 1986
- Effect of heparin on vascular smooth muscle cells. II. Specific protein synthesisJournal of Cellular Physiology, 1985
- Binding and internalization of heparin by vascular smooth muscle cellsJournal of Cellular Physiology, 1985
- Heparin regulates the collagen phenotype of vascular smooth muscle cells: induced synthesis of an Mr 60,000 collagen.The Journal of cell biology, 1985
- Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growthThe Journal of cell biology, 1981
- Suppression by heparin of smooth muscle cell proliferation in injured arteriesNature, 1977